News

Giving nitrous oxide as part of general anesthesia for noncardiac surgery doesn’t increase the rate of complications and death – and might even decrease the risk of such events, according to a pair of studies in the May issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS). But an accompanying […]

Continue reading about Two Studies Add New Data To Debate Over Safety Of N2O As Surgical Anesthetic

Dott. Luigi Vicari on 28 aprile 2013

Drinking one 12-ounce sugar-sweetened soft drink a day can increase the risk of type 2 diabetes by 22%, a new study from Europe suggests. The results corroborate research conducted in North American populations. Collectively, the findings suggest that “clear” population-based messages on the deleterious effect of these beverages on health “should be given,” the study […]

Continue reading about Newest Study Confirms a Soda a Day Ups Diabetes Risk by 20%

Dott. Luigi Vicari on 28 aprile 2013

Scientists from the Manchester Collaborative Centre for Inflammation Research (MCCIR) have discovered why a particular cancer drug is so effective at killing cells. Their findings could be used to aid the design of future cancer treatments. Professor Daniel Davis and his team used high quality video imaging to investigate why the drug rituximab is so […]

Continue reading about Cancer Cells’ Achilles’ Heel Revealed

Dott. Luigi Vicari on 3 marzo 2013

Compared with placebo, the selective serotonin and noradrenaline reuptake inhibitors (SNRIs) duloxetine (Cymbalta) and milnacipran (Savella) are slightly more likely to reduce pain in patients with fibromyalgia syndrome (FMS), according to a new Cochrane meta-analysis. However, they’re not substantially superior in terms of reducing fatigue and sleep problems or in improving quality of life, and […]

Continue reading about Small Benefit of SNRIs for Fibromyalgia Pain

Dott. Luigi Vicari on 12 febbraio 2013

Bathing hospital patients with chlorhexidine-impregnated wipes improves infection control in critical care units plagued by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE), according to a study published online February 6 in the New England Journal of Medicine.

Continue reading about Chlorhexidine Baths Protect Patients in the ICU